| 1247 |
Procedure for Culture Specimen Processing: Pulmonary specimens |
04/06/2024 |
Laboratory services and management |
| 1248 |
Procedure for Culture Specimen Processing: Extrapulmonary specimens |
04/06/2024 |
Laboratory services and management |
| 1249 |
Procedure for Culture Specimen Processing: Pus and other muco-purulent specimens |
04/06/2024 |
Laboratory services and management |
| 1250 |
Procedure for Culture Specimen Processing: Gastric Aspirate |
04/06/2024 |
Laboratory services and management |
| 1252 |
LPA: Principles and Technique |
04/06/2024 |
Laboratory services and management |
| 1253 |
Line Probe Assay [LPA] in DR-TB Diagnosis |
04/06/2024 |
Laboratory services and management |
| 1273 |
Limitations of First-line Line Probe Assay [FL-LPA] |
04/06/2024 |
Laboratory services and management |
| 1278 |
Limitations of Second-line Line Probe Assay [SL-LPA] |
04/06/2024 |
Laboratory services and management |
| 1286 |
Truenat DNA Extraction Cartridge |
04/06/2024 |
Laboratory services and management |
| 1290 |
TrueNAT Sample Processing: Other Body Fluids |
04/06/2024 |
Laboratory services and management |
| 1292 |
Truenat MTB Assay Results Interpretation: Visualization |
04/06/2024 |
Laboratory services and management |
| 1293 |
TrueNAT MTB Assay Results Interpretation: Detection of Mycobacterium tuberculosis and RIF Resistance |
04/06/2024 |
Laboratory services and management |
| 1294 |
TrueNAT MTB Assay Results Interpretation - Indeterminate |
04/06/2024 |
Laboratory services and management |
| 1296 |
Maintenance of the Truenat Instrument - General Principles |
04/06/2024 |
Laboratory services and management |
| 1298 |
External Quality Assurance of TrueNAT |
04/06/2024 |
Laboratory services and management |
| 1303 |
Visualization of CBNAAT Test Results |
04/06/2024 |
Laboratory services and management |
| 1305 |
Troubleshooting Process for CBNAAT |
04/06/2024 |
Laboratory services and management |
| 1311 |
Maintenance of CBNAAT Instrument under NTEP |
04/06/2024 |
Laboratory services and management |
| 1314 |
Monitoring of CBNAAT Quality Indicators |
04/06/2024 |
Laboratory services and management |
| 1318 |
Diagnostic Tools Used in Non-tuberculous Mycobacterial [NTM] Infection |
04/06/2024 |
Laboratory services and management |
| 1331 |
Personal Protective Equipment [PPE] Use in TB Lab Settings |
04/06/2024 |
Laboratory services and management |
| 1338 |
Exposure to Tuberculosis Bacilli and risk of infection |
04/06/2024 |
Laboratory services and management |
| 1350 |
Fluorescence Microscopy |
04/06/2024 |
Laboratory services and management |
| 1354 |
Inbuilt Controls of CBNAAT Technology |
04/06/2024 |
Laboratory services and management |
| 1359 |
WHO Recommended SOPs for Xpert MTB/RIF Sample Processing |
04/06/2024 |
Laboratory services and management |
| 1361 |
Indications for retesting in CBNAAT |
04/06/2024 |
Laboratory services and management |
| 1363 |
Storage of Slides for QA |
04/06/2024 |
Laboratory services and management |
| 1364 |
Preparation of Reagents for FM Microscopy |
04/06/2024 |
Laboratory services and management |
| 1367 |
PCR Amplification of the Target genes in Truenat |
04/06/2024 |
Laboratory services and management |
| 1371 |
Interfering Substances causing errors in NAAT Assay |
04/06/2024 |
Laboratory services and management |
